NO307548B1 - Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse - Google Patents

Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse

Info

Publication number
NO307548B1
NO307548B1 NO944405A NO944405A NO307548B1 NO 307548 B1 NO307548 B1 NO 307548B1 NO 944405 A NO944405 A NO 944405A NO 944405 A NO944405 A NO 944405A NO 307548 B1 NO307548 B1 NO 307548B1
Authority
NO
Norway
Prior art keywords
tablet
improved bioavailability
active compound
diphosphonic acid
dichloromethylene diphosphonic
Prior art date
Application number
NO944405A
Other languages
English (en)
Norwegian (no)
Other versions
NO944405L (no
NO944405D0 (no
Inventor
Walter Preis
Bernd Muesel
Guenter Neugebauer
Rolf-Dieter Gabel
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25927331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO307548(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE9307393U external-priority patent/DE9307393U1/de
Priority claimed from DE19934322057 external-priority patent/DE4322057A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of NO944405D0 publication Critical patent/NO944405D0/no
Publication of NO944405L publication Critical patent/NO944405L/no
Publication of NO307548B1 publication Critical patent/NO307548B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO944405A 1993-05-15 1994-11-17 Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse NO307548B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE9307393U DE9307393U1 (de) 1993-05-15 1993-05-15 Tablette mit verbesserter Bioverfügbarkeit, enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
DE19934322057 DE4322057A1 (de) 1993-07-02 1993-07-02 Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
PCT/EP1993/001967 WO1994026310A1 (de) 1993-05-15 1993-07-24 Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff

Publications (3)

Publication Number Publication Date
NO944405D0 NO944405D0 (no) 1994-11-17
NO944405L NO944405L (no) 1994-11-24
NO307548B1 true NO307548B1 (no) 2000-04-25

Family

ID=25927331

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944405A NO307548B1 (no) 1993-05-15 1994-11-17 Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse

Country Status (25)

Country Link
US (1) US5650168A (da)
EP (2) EP0697890A1 (da)
JP (1) JP3699110B2 (da)
KR (1) KR100263284B1 (da)
CN (1) CN1041797C (da)
AT (2) ATE128363T1 (da)
AU (1) AU687744B2 (da)
BR (1) BR9307859A (da)
CA (1) CA2162470C (da)
CZ (1) CZ287984B6 (da)
DE (1) DE59300688D1 (da)
DK (1) DK0625355T5 (da)
ES (1) ES2065313T5 (da)
FI (1) FI111519B (da)
GR (2) GR940300095T1 (da)
HU (1) HU220872B1 (da)
IL (1) IL106743A (da)
NO (1) NO307548B1 (da)
NZ (1) NZ254765A (da)
PL (1) PL173026B1 (da)
RU (1) RU2134103C1 (da)
SK (1) SK281193B6 (da)
TW (1) TW350772B (da)
UA (1) UA39884C2 (da)
WO (1) WO1994026310A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
CZ289261B6 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
UA85850C2 (uk) * 2003-09-19 2009-03-10 Сан Фарма Адвансед Ресьорч Компані Лтд. Оральна система доставки лікарського препарату
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US7151400B2 (en) * 2004-07-13 2006-12-19 Taiwan Semiconductor Manufacturing Company, Ltd. Boost-biased level shifter
CN100370972C (zh) * 2006-01-10 2008-02-27 北京申科联华科技有限公司 一种具有益气养阴、活血复脉功效的片剂及制备方法
KR20100045450A (ko) * 2007-08-02 2010-05-03 데이진 화-마 가부시키가이샤 골 대사 이상에서 기인하는 질환의 예방제 또는 치료제
EP2242485A4 (en) * 2008-02-15 2013-05-08 Sun Pharma Advanced Res Co Ltd ORAL TABLET WITH CONTROLLED RELEASE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2813121A1 (de) * 1977-03-29 1978-10-12 Procter & Gamble Verwendung von dichlormethan-diphosphonatverbindungen bei der bekaempfung von collagen-erkrankungen und zur wundheilung
US4634691A (en) * 1980-10-07 1987-01-06 The Procter & Gamble Company Method for inhibiting tumor metastasis
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
ATE60711T1 (de) * 1986-12-20 1991-02-15 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
FI83421C (fi) † 1989-06-21 1991-07-10 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat.
ATE119777T1 (de) * 1991-02-26 1995-04-15 Procter & Gamble Pharma Behandlungsmethoden für osteoporose.
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
EP0675723A4 (en) * 1992-12-23 1998-08-05 Merck & Co Inc BIPHOSPHONATE / ESTROGEN THERAPY FOR TREATING AND PREVENTING BONE LOSS.

Also Published As

Publication number Publication date
ATE128363T1 (de) 1995-10-15
DE59300688D1 (de) 1995-11-02
CN1095267A (zh) 1994-11-23
TW350772B (en) 1999-01-21
NO944405L (no) 1994-11-24
CA2162470A1 (en) 1994-11-24
NO944405D0 (no) 1994-11-17
ES2065313T3 (es) 1995-12-01
HUT70214A (en) 1995-09-28
JP3699110B2 (ja) 2005-09-28
DK0625355T5 (da) 2003-12-01
GR940300095T1 (en) 1995-01-31
EP0625355A1 (de) 1994-11-23
HU9403160D0 (en) 1995-02-28
CA2162470C (en) 1998-06-16
RU2134103C1 (ru) 1999-08-10
FI945313A (fi) 1994-12-13
FI111519B (fi) 2003-08-15
NZ254765A (en) 1997-02-24
SK281193B6 (sk) 2001-01-18
AT128U1 (de) 1995-03-27
EP0625355B2 (de) 2003-06-25
CZ10095A3 (en) 1995-10-18
KR100263284B1 (ko) 2000-08-01
US5650168A (en) 1997-07-22
DK0625355T3 (da) 1995-12-27
FI945313A0 (fi) 1994-11-11
HU220872B1 (en) 2002-06-29
BR9307859A (pt) 1996-01-09
UA39884C2 (uk) 2001-07-16
SK4895A3 (en) 1997-01-08
JPH08509697A (ja) 1996-10-15
KR960702322A (ko) 1996-04-27
EP0625355B1 (de) 1995-09-27
WO1994026310A1 (de) 1994-11-24
CZ287984B6 (cs) 2001-03-14
PL307133A1 (en) 1995-05-02
ES2065313T5 (es) 2004-01-01
ES2065313T1 (es) 1995-02-16
AU687744B2 (en) 1998-03-05
DK0625355T4 (da) 2003-10-06
EP0697890A1 (de) 1996-02-28
AU4702093A (en) 1994-12-12
IL106743A (en) 1999-11-30
GR3017547T3 (en) 1995-12-31
CN1041797C (zh) 1999-01-27
PL173026B1 (pl) 1998-01-30
IL106743A0 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
NO944405D0 (no) Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse
UY23804A1 (es) Procedimiento de preparacion de medicamentos en forma de comprimidos con liberacion retardada de sustancia activa.
DK1027037T3 (da) Farmaceutisk præparat som indeholder clodronat som aktiv ingrediens og forkislet mikrokrystallinsk cellulose som excipiens
BR9506029A (pt) Forma farmaêutica oral de múltipla dosagem unitária em tablete processo para a preparação da mesma para a inibição da secreção de ácido gástrico em mamiferos e no homem para o tratamento de doenças inflamatórias gastrointestinais em maniferos e no homem e embalgem de ampola de pressão transversal
MXPA03007712A (es) Sales farmaceuticas.
DK0497158T3 (da) Farmaceutisk tyggegummi med acetylsalicylsyre
NZ279062A (en) Use of phenylazosalicylic acid derivatives for treatment/prevention of colon cancer
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
SE9003904D0 (sv) Method for the manufacture of a pharmaceutical dosage form
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
UA66925C2 (uk) Поліморфні форми кристалічного цитрату азабіцикло[2.2.2]-октан-3-аміну, спосіб їх одержання, фармацевтична композиція та спосіб лікування блювання
DK0667151T3 (da) Oralt lægemiddelpræparat indeholdende diclofenacnatrium og en organisk syre
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
SE8105500L (sv) Psykotropa lekemedel
IT1271354B (it) Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi
RU93058142A (ru) Производные хинолина, способ их получения, фармацевтическая композиция и способ лечения

Legal Events

Date Code Title Description
MK1K Patent expired